News

By Viviane Trojan

September 9, 2024

Brazil Implements a New Regulatory Framework for Food Products

The newly implemented regulatory framework governing food safety and quality in Brazil took effect on September 1st, 2024. The Collegiate Board Resolutions Brazil Implements a New Regulatory Framework for Food Products

Ler notícia

July 2, 2024

Life Sciences’ Brazil Global Guide 2024 is now available

We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide! Our partners Priscila Kashiwabara Life Sciences’ Brazil Global Guide 2024 is now available

Ler notícia

June 7, 2024

BRPTO Publishes Integrity Plan for 2024-2025

On Tuesday, June 4, 2024, the Brazilian Patent and Trademark Office (”INPI”) published its Integrity Plan, outlining actions to manage integrity risks BRPTO Publishes Integrity Plan for 2024-2025

Ler notícia

May 29, 2024

New Regulation Approved by Anvisa Simplifies the Registration Process for Biosimilar Medicines

Anvisa approved the new simplified regulation for the registration of biosimilar medicines, whose publication in the Official Gazette (DOU) is still awaited. New Regulation Approved by Anvisa Simplifies the Registration Process for Biosimilar Medicines

Ler notícia

April 30, 2024

Trade secrets: a strategic element in the life sciences and biotechnology industries

Our partner Viviane Trojan was invited by the International Bar Association (IBA) to write an article for their platform. She authored the Trade secrets: a strategic element in the life sciences and biotechnology industries

Ler notícia

April 29, 2024

Celebrating the World Intellectual Property Day, Kasznar Leonardos launches Brazilian Patent Litigation Guide

In celebration of World Intellectual Property Day, we invite you to delve into ‘Brazilian Patent Litigation: 2022/2023 in Review,’ a collaborative effort Celebrating the World Intellectual Property Day, Kasznar Leonardos launches Brazilian Patent Litigation Guide

Ler notícia

April 17, 2024

Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines

Anvisa recently launched a public notice with the aim of selecting Startups involved in the research and development of medicines, in order Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines

Ler notícia

December 22, 2023

2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

Ler notícia

December 18, 2023

Industrial Design Registration: new BRPTO opinion on the scope of appeal

As recently reported, the BRPTO announced a series of new guidelines regarding the processing of patent, trademark and industrial design applications. Check Industrial Design Registration: new BRPTO opinion on the scope of appeal

Ler notícia

December 15, 2023

The BRPTO ruled that it is not possible to amend a patent application during the appeal phase

On Tuesday, December 12, 2023, the BRPTO published new rules that limit applicants’ acts in the administrative process for granting patents. At the The BRPTO ruled that it is not possible to amend a patent application during the appeal phase

Ler notícia

December 12, 2023

Anvisa approves skinny labeling practice in Brazil

Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with Anvisa approves skinny labeling practice in Brazil

Ler notícia
plugins premium WordPress